1. Hunter SM, Johansen-Berg H, Ward N, Kennedy NC, Chandler E, Weir CJ, Rothwell J, Wing AM, Grey MJ, Barton G et al: Functional Strength Training and Movement Performance Therapy for Upper Limb Recovery Early Poststroke-Efficacy, Neural Correlates, Predictive Markers, and Cost-Effectiveness: FAST-INdiCATE Trial. Frontiers in Neurology 2018, 8.
2. Winkel P, Bath PM, Gluud C, Lindschou J, van der Worp HB, Macleod MR, Szabo I, Durand-Zaleski I, Schwab S, Euro HYPTI: Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke. Trials 2017, 18.
3. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B et al: 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2018, 49(3):E46-E110.
4. Ichijo M, Iwasawa E, Numasawa Y, Miki K, Ishibashi S, Tomita M, Tomimitsu H, Kamata T, Fujigasaki H, Shintani S et al: Significance of Development and Reversion of Collaterals on MRI in Early Neurologic Improvement and Long-Term Functional Outcome after Intravenous Thrombolysis for Ischemic Stroke. American Journal of Neuroradiology 2015, 36(10):1839-1845.
5. Miettinen JA, Ylitalo K, Hedberg P, Jokelainen J, Kervinen K, Niemela M, Saily M, Koistinen P, Savolainen ER, Ukkonen H et al: Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy. Heart 2010, 96(5):362-367.
6. Fazzone B, Morris G, Black LA, Williams JA, Leacock R, Sternberg S, Blackhurst D, Nelson A, Nathaniel IT: Exclusion and Inclusion Criteria for Thrombolytic Therapy in an Ischemic Stroke Population.e 4(2): 1112. J Neurol Disord Strok 2016, 4(2):1-5.
7. Fredwall M, Sternberg S, Blackhurst D, Lee A, Leacock R, Nathaniel TI: Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator. Journal of Stroke & Cerebrovascular Diseases 2016, 25(11):2569-2574.
8. Cochran T, Chaves J, Fulmer E, Blackhurst D, Sternberg S, Leacock R, Nathaniel T: Analysis of Comorbidities in Ischemic Stroke Patient. Neurology 2014, 82(10):Supplement P6.278.
9. Kumar D, Gubbi J, Yan B, Palaniswami M, Ieee: Motor recovery monitoring in post acute stroke patients using wireless accelerometer and cross-correlation. In: 2013 35th Annual International Conference of the Ieee Engineering in Medicine and Biology Society. edn.; 2013: 6703-6706.
10. Langhorne P, Coupar F, Pollock A: Motor recovery after stroke: a systematic review. Lancet Neurology 2009, 8(8):741-754.
11. Veerbeek JM, Winters C, van Wegen EEH, Kwakkel G: Is the proportional recovery rule applicable to the lower limb after a first-ever ischemic stroke? PloS one 2018, 13(1).
12. Stinear CM, Byblow WD, Ackerley SJ, Smith MC, Borges VM, Barber PA: Proportional Motor Recovery After Stroke: Implications for Trial Design. Stroke 2017, 48(3):795-798.
13. Nathaniel TI, Cochran T, Chaves J, Fulmer E, Sosa C, Yi S, Fredwall M, Sternberg S, Blackhurst D, Nelson A et al: Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke. Brain injury 2016, 30(10):1261-1265.
14. Colello MJ, Ivey LE, Gainey J, Faulkner RV, Johnson A, Brechtel L, Madeline L, Nathaniel TI: Pharmacological thrombolysis for acute ischemic stroke treatment: Gender differences in clinical risk factors. Advances in Medical Sciences 2018, 63(1):100-106.
15. Gainey J, Brechtel L, Konklin S, Madeline L, Lowther E, Blum B, Nathaniel TI: In a stroke cohort with incident hypertension; are more women than men likely to be excluded from recombinant tissue-type Plasminogen Activator (rtPA)? Journal of the neurological sciences 2018, 387:139-146.
16. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. International Journal of Surgery 2014, 12(12):1495-1499.
17. Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, Ellrodt G, Cannon CP, Liang L, Peterson E et al: Get With the Guidelines-Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack. Circulation 2009, 119(1):107-U206.
18. Whisnant JP, Basford JR, Bernstein EF: Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990, 4:637-676.
19. Lawson TR, Brown IE, Westerkam DL, Blackhurst DW, Sternberg S, Leacock R, Nathaniel TI: Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation. Restorative Neurology and Neuroscience 2015, 33(3):301-308.
20. Wang M, He Y, Shi L, Shi C: Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer. European Journal of Gynaecological Oncology 2011, 32(2):171-177.
21. Sullivan LM, Massaro JM, D'Agostmo RB: Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Statistics in Medicine 2004, 23(10):1631-1660.
22. Perez-Guaita D, Kuligowski J, Garrigues S, Quintas G, Wood BR: Assessment of the statistical significance of classifications in infrared spectroscopy based diagnostic models. Analyst 2015, 140(7):2422-2427.
23. Bathke A: Testing monotone effects of covariates in nonparametric mixed models. Journal of Nonparametric Statistics 2005, 17(4):423-439.
24. Costello CA, Campbell BC, Perez dLA, Ossa N: Age over 80 years is not associated with increased hemorrhagic transformation after stroke thrombolysis. J Clin Neurosci 2012, 19:360-363.
25. Behrouz R, Masjuan-Vallejo J, Vera R, Willey JZ, Zedet M, Moulin S, Cordonnier C, Klijn CJM, Kanselaar K, Dirks M et al: Outcomes of Nonagenarians with Acute Ischemic Stroke Treated with Intravenous Thrombolytics. Journal of Stroke & Cerebrovascular Diseases 2018, 27(1):246-256.
26. Doshi R, Patel V, Shah P: Comparison of in-hospital outcomes between octogenarians and nonagenarians undergoing transcatheter aortic valve replacement: a propensity matched analysis. Journal of Geriatric Cardiology 2018, 15(2):123-130.
27. Schneider JR, Jackson CR, Helenowski IB, Verta MJ, Wilkinson JB, Kim S, Hoel AW: A comparison of results of carotid endarterectomy in octogenarians and nonagenarians to younger patients from the Mid-America Vascular Study Group and the Society for Vascular Surgery Vascular Quality Initiative. Journal of Vascular Surgery 2017, 65(6):1643-1652.
28. Hosp JA, Luft AR: Cortical Plasticity during Motor Learning and Recovery after Ischemic Stroke. Neural Plasticity 2011.
29. Kwakkel G, Kollen B, Lindeman E: Understanding the pattern of functional recovery after stroke: Facts and theories. Restorative Neurology and Neuroscience 2004, 22(3-5):281-299.
30. Smith EE, Fonarow GC, Reeves MJ: Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from get with the guidelines-stroke. stroke 2011, 42(11):3110–3115.
31. Yang J, Yu F, Liu H, An HD, Xiong R, Huang DY: A Retrospective Study of thrombolysis with 0.6 mg/kg Recombinant Tissue Plasminogen Activator (rt-PA) in Mild Stroke. Scientific Reports 2016, 6.
32. Chen WQ, Pan YS, Zhao XQ, Liu LP, Li H, Liao XL, Wang CJ, Wang YL, Wang YJ: Intravenous Thrombolysis in Chinese Patients with Different Subtype of Mild Stroke: Thrombolysis in Patients with Mild Stroke. Scientific Reports 2017, 7.
33. Tan YF, Zhan LX, Chen XH, Guo JJ, Qin C, Xu E: Risk Factors, Clinical Features and Prognosis for Subtypes of Ischemic Stroke in a Chinese Population. Current Medical Science 2018, 38(2):296-303.
34. Wapshott T, Blum B, Williams K, Nathaniel TI: Investigation of Gender Differences and Exclusive Criteria in a Diabetic Acute Ischemic Stroke Population Treated with Recombinant Tissue-Type Plasminogen Activator (rtPA). J Vasc Interv Neurol 2017, 9(6):26-32.
35. Chen SY, Winstein CJ: A Systematic Review of Voluntary Arm Recovery in Hemiparetic Stroke Critical Predictors for Meaningful Outcomes Using the International Classification of Functioning, Disability, and Health. Journal of Neurologic Physical Therapy 2009, 33(1):2-13.